Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia

Patients with acute myeloid leukemia have a very poor prognosis related to a high rate of relapse and drug-related toxicity. The ability of leukemia stem cells (LSCs) to survive chemotherapy is primarily responsible for relapse, and eliminating LSCs is ultimately essential for cure. We developed nov...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nanomedicine
Auteurs principaux: Lin, Tzu-yin, Zhu, Yanjun, Li, Yuanpei, Zhang, Hongyong, Ma, Ai-Hong, Long, Qilai, Keck, James, Lam, Kit S., Pan, Chong-xian, Jonas, Brian A.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8237247/
https://ncbi.nlm.nih.gov/pubmed/31055076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2019.04.007
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires